Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

Application of PET/MRI in Gynecologic Malignancies.

Application of PET/MRI in Gynecologic Malignancies. Cancers Ebrahimi, S., Lundstrom, E., Batasin, S. J., Hedlund, E., Stalberg, K., Ehman, E. C., Sheth, V. R., Iranpour, N., Loubrie, S., Schlein, A., Rakow-Penner, R. 2024; 16 (8)

Abstract

The diagnosis, treatment, and management of gynecologic malignancies benefit from both positron emission tomography/computed tomography (PET/CT) and MRI. PET/CT provides important information on the local extent of disease as well as diffuse metastatic involvement. MRI offers soft tissue delineation and loco-regional disease involvement. The combination of these two technologies is key in diagnosis, treatment planning, and evaluating treatment response in gynecological malignancies. This review aims to assess the performance of PET/MRI in gynecologic cancer patients and outlines the technical challenges and clinical advantages of PET/MR systems when specifically applied to gynecologic malignancies.

View details for DOI 10.3390/cancers16081478

View details for PubMedID 38672560